Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Genetic screening of multiple endocrine neoplasia type 2: experience of the USP Endocrine Genetics Unit].

Arquivos brasileiros de endocrinologia e metabologia - 1 Feb 2006

Santos Marcelo A C G dos, Nunes Adriana Bezerra, Abelin Neusa, Ezabella Marilza C L, Toledo Rodrigo de Almeida, Lourenço Delmar, Hayashida Cesar Yoiti, Fonseca Ivone Izabel M da, Toledo Sergio P de Almeida

Abstract excerpt

Multiple endocrine neoplasia type 2 (MEN-2) is an inherited tumor syndrome that includes medullary thyroid carcinoma (MTC), primary hyperparathyroidism, pheochromocytoma and other non-endocrine diseases. Since the first RET missense mutations in association with MEN-2 were identified, RET mutation analysis had a great impact in the clinical management of MEN-2, such as in early diagnosis and treatment of MTC....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Carcinoma, Medullary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Genetic Testing

Share to Multiple Endocrine Neoplasia Type 2a

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins c-ret

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 16628270
DOI: 10.1590/s0004-27302006000100003

Genes

RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Genetic screening of multiple endocrine neoplasia type 2: experience of the USP Endocrine Genetics Unit].PMID 16628270Read ↗

[Clinical features and mutations of RET proto-oncogene in a pedigree affected with type 2A multiple endocrine neoplasia].Semantic proximity Read ↗

Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.Semantic proximity Read ↗

Genotype-phenotype correlation of patients with multiple endocrine neoplasia type 2 in Japan.Semantic proximity Read ↗

Clinical significance of RET mutation screening in a pedigree of multiple endocrine neoplasia type 2A.Semantic proximity Read ↗

[A comparison of clinical characteristics between 2 pedigrees of multiple endocrine neoplasia type 2A with different RET mutations].Semantic proximity Read ↗

[Genetic analysis of RET mutations in families with multiple endocrine neoplasia type II in the community of Murcia].Semantic proximity Read ↗

[The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].Semantic proximity Read ↗

[Ret proto-oncogene mutations associated with type 2 multiple endocrine neoplasms (MEN 2). Clinical implications].Semantic proximity Read ↗

[DelD631: a novel mutation of the RET proto-oncogene in multiple endocrine neoplasia type 2A (MEN2A)].Semantic proximity Read ↗

Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene.Semantic proximity Read ↗

Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.Semantic proximity Read ↗

[Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.